Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stem (STEM) Non-Current Debt (2020 - 2025)

Stem has reported Non-Current Debt over the past 6 years, most recently at $128.8 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $128.8 million for Q4 2025, up 209.4% from a year ago — trailing twelve months through Dec 2025 was $128.8 million (up 209.4% YoY), and the annual figure for FY2025 was $128.8 million, up 209.4%.
  • Non-Current Debt for Q4 2025 was $128.8 million at Stem, up from $31.1 million in the prior quarter.
  • Over the last five years, Non-Current Debt for STEM hit a ceiling of $128.8 million in Q4 2025 and a floor of $1.6 million in Q3 2022.
  • Median Non-Current Debt over the past 5 years was $46.0 million (2024), compared with a mean of $46.0 million.
  • Biggest five-year swings in Non-Current Debt: surged 3803.55% in 2022 and later crashed 97.61% in 2023.
  • Stem's Non-Current Debt stood at $1.7 million in 2021, then soared by 3685.83% to $63.9 million in 2022, then fell by 18.57% to $52.0 million in 2023, then dropped by 19.96% to $41.6 million in 2024, then surged by 209.4% to $128.8 million in 2025.
  • The last three reported values for Non-Current Debt were $128.8 million (Q4 2025), $31.1 million (Q3 2025), and $126.7 million (Q2 2025) per Business Quant data.